Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Recruiting 3Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 5Lymphoid 2Plasma cell 1

Conditions

Breast Neoplasms 233Neoplasms 163Prostatic Neoplasms 143Colorectal Neoplasms 105Lung Neoplasms 97Leukemia, Myeloid, Acute 74Pancreatic Neoplasms 72Carcinoma, Non-Small-Cell Lung 71Multiple Myeloma 61Brain Neoplasms 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Melanoma 51Glioblastoma 48Carcinoma, Hepatocellular 45Ovarian Neoplasms 44Head and Neck Neoplasms 43Uterine Cervical Neoplasms 41Neoplasm Metastasis 41Sarcoma 40Glioma 39Stomach Neoplasms 37Hematologic Neoplasms 37Squamous Cell Carcinoma of Head and Neck 35Recurrence 35Lymphoma, Non-Hodgkin 34Carcinoma, Renal Cell 34Esophageal Neoplasms 33Lymphoma 32Leukemia 32Rectal Neoplasms 31

Interventions

Cyclophosphamide 2pembrolizumab 1fludarabine phosphate 1fludarabine 1Surveys and Questionnaires 1Mesna 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Leukemia, Lymphoid × 30 days × Clear all
NCT05865301 2026-06-04

Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy

Stanford University

Recruiting
500 enrolled
Other hematologic neoplasm

Leukemia, Lymphoid

NCT03219450 2026-05-28

A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.

Dana-Farber Cancer Institute

Phase 1 Recruiting
15 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Lymphoid

NCT03573700 2026-05-20

Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia

St. Jude Children's Research Hospital

Phase 1/2 Active not recruiting
24 enrolled 9 charts
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphoid, Recurrence, Leukemia, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07566364 2026-05-20

Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD

M.D. Anderson Cancer Center

Phase 2 Not yet recruiting
30 enrolled
Other hematologic neoplasm

Leukemia, Lymphoid

NCT07292272 2026-05-18

HALTAging-1

University of Nebraska

Phase 2 Recruiting
180 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Lymphoma, Non-Hodgkin, Multiple Myeloma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡